174 related articles for article (PubMed ID: 2539064)
41. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
Chabowski M; Orłowski TM; Rabczenko D
Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
[TBL] [Abstract][Full Text] [Related]
43. Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases.
Terzi A; Lonardoni A; Falezza G; Scanagatta P; Santo A; Furlan G; Calabrò F
Eur J Cardiothorac Surg; 2002 Jul; 22(1):30-4. PubMed ID: 12103369
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
[TBL] [Abstract][Full Text] [Related]
45. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
[TBL] [Abstract][Full Text] [Related]
46. Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival.
Alexiou C; Beggs D; Onyeaka P; Kotidis K; Ghosh S; Beggs L; Hopkinson DN; Duffy JP; Morgan WE; Rocco G
Ann Thorac Surg; 2003 Oct; 76(4):1023-8. PubMed ID: 14529978
[TBL] [Abstract][Full Text] [Related]
47. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
48. Modality of failure following resection of stage I and stage II non-small cell lung cancer.
Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G
Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234
[TBL] [Abstract][Full Text] [Related]
49. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
50. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
51. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
52. Do Margins Really Affect Prognosis in Wedge Resection for Early-Stage Lung Cancer?
Baisi A; Raveglia F; De Simone M; Cioffi U
Ann Thorac Surg; 2016 Apr; 101(4):1629. PubMed ID: 27000595
[No Abstract] [Full Text] [Related]
53. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type.
Choi YS; Shim YM; Kim K; Kim J
J Korean Med Sci; 2004 Oct; 19(5):674-6. PubMed ID: 15483342
[TBL] [Abstract][Full Text] [Related]
54. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
[TBL] [Abstract][Full Text] [Related]
55. [Influence of blood transfusion on postoperative prognosis of stage I (No) lung cancer].
Wu HS
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):297-9. PubMed ID: 2560426
[TBL] [Abstract][Full Text] [Related]
56. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
57. Results of long-term follow-up of patients with completely resected non-small cell lung cancer.
Endo C; Sakurada A; Notsuda H; Noda M; Hoshikawa Y; Okada Y; Kondo T
Ann Thorac Surg; 2012 Apr; 93(4):1061-8. PubMed ID: 22386090
[TBL] [Abstract][Full Text] [Related]
58. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?
Churchhouse AM; Mathews TJ; McBride OM; Dunning J
Interact Cardiovasc Thorac Surg; 2012 Jan; 14(1):85-90. PubMed ID: 22108935
[TBL] [Abstract][Full Text] [Related]
59. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
Feld R; Rubinstein L; Thomas PA
Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
